CEO Club Briefing

Christopher A. Viehbacher

Chief Executive Officer, Sanofi, and Chairman, Genzyme Corporation

Christopher A. Viehbacher

Chief Executive Officer, Sanofi, and Chairman, Genzyme Corporation

Current and Future Innovations in the Worldwide Pharmaceutical and Health Care Industries

Sanofi Chief Executive Officer and Genzyme Corporation Chairman Christopher A. Viehbacher talked about his company’s local investments (Sanofi subsidiary Genzyme’s headquarters are in Cambridge), and called for new funding models for drug research at the March 6 Chief Executives’ Club of Boston. Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific, Inc., introduced Viehbacher.